Live Breaking News & Updates on Milestones Expected

Stay updated with breaking news from Milestones expected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights

02.05.2024 - - Completed additional enrollment in Phase 1B dose-expansion cohorts for TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) patients in the first quarter of 2024; updated combination data expected at the European Society of Hematology (EHA) 2024 . ....

United States , North Carolina , Mirvetuximab Soravtansine , Conor Richardson , Clay Siegall , Kate Sasser , Taylor Schreiber , Exchange Commission , Ono Pharmaceutical Co Ltd , Development Rd Expenses , Shattuck Labs Inc , American Association For Cancer Research , Cancer Research , Annual Meeting , Chief Executive Officer , Ono Pharma , Milestones Expected , Platinum Resistant Ovarian Cancer , Cancer Cell , Ono Enter , Collaboration Agreement , Appoints Clay Siegall , Cash Equivalents , Clinical Trial , Shattuck Labs , Agonist Redirected Checkpoint ,

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

- Announced positive topline data from the ongoing Phase 1A/B clinical trial of SL-172154 in combination with azacitidine (AZA) in frontline Highe. ....

United States , North Carolina , Conor Richardson , Mirvetuximab Soravtansine , Taylor Schreiber , American Society Of Hematology , Exchange Commission , Shattuck Labs Inc , Cancer Research , Ono Pharmaceutical Co Ltd , Health Care Conference Boston , Development Rd Expenses , Rna Work In Cancer Research , Higher Risk Myelodysplastic Syndromes , Acute Myeloid Leukemia , American Society , Annual Meeting , Chief Executive Officer , Cancer Cell , Milestones Expected , Stage Pipeline , Initial Enrollment , Ongoing Phase , Clinical Trial , Presented Positive Interim Data , Acquired Resistance ,

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

- Announced positive topline data from the ongoing Phase 1A/B clinical trial of SL-172154 in combination with azacitidine in frontline Higher-Risk Myelodysplastic Syndromes and frontline TP53 mutant. ....

United States , North Carolina , Taylor Schreiber , Conor Richardson , Mirvetuximab Soravtansine , Cancer Research , Rna Work In Cancer Research , Shattuck Labs Inc , Ono Pharmaceutical Co Ltd , Exchange Commission , Development Rd Expenses , Health Care Conference Boston , American Society Of Hematology , Higher Risk Myelodysplastic Syndromes , Acute Myeloid Leukemia , American Society , Annual Meeting , Chief Executive Officer , Cancer Cell , Milestones Expected , Stage Pipeline , Initial Enrollment , Ongoing Phase , Clinical Trial , Presented Positive Interim Data , Acquired Resistance ,

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024

AUSTIN, TX and DURHAM, NC, Jan. 08, 2024 Shattuck Labs, Inc. , a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic. ....

United States , North Carolina , San Francisco , Conor Richardson , Taylor Schreiber , Exchange Commission , American Society Of Clinical Oncology , Shattuck Labs Inc , American Society Of Hematology Annual Meeting , Chief Executive Officer , Resistant Ovarian Cancer , American Society , Clinical Oncology , Risk Myelodysplastic Syndromes , Acute Myeloid Leukemia , Hematology Annual , Milestones Expected , Financial Guidance , Healthcare Conference , Corporate Presentation , Shattuck Labs , Agonist Redirected Checkpoint , Annual Report , Safe Harbor , Private Securities Litigation Reform Act , Media Contact ,

Shattuck Labs (STTK) Provides Corporate Update and Highlights Upcoming Key Milestones in 2024

Shattuck Labs (STTK) Provides Corporate Update and Highlights Upcoming Key Milestones in 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Taylor Schreiber , American Society Of Hematology Annual Meeting , American Society Of Clinical Oncology , Shattuck Labs Inc , Shattuck Labs , Chief Executive Officer , Resistant Ovarian Cancer , American Society , Clinical Oncology , Risk Myelodysplastic Syndromes , Acute Myeloid Leukemia , Hematology Annual , Milestones Expected , Financial Guidance , Chief Executive ,